AzTrials
AzTrials

CraniosynostosesCraNIRSNCT04086056

CraNIRS Clinical Study

An observational study of Craniosynostoses, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Craniosynostosis is a rare disorder characterized by a premature fusion of one or more sutures of the skull. Craniosynostosis is usually diagnosed in the first years of life. Several complications may be identified if untreated, notably, developmental delay, and vision problems. Read more about this study

Who is it for?
Ages 3 to 18 months
Conditions the study is for
Craniosynostoses
What is being tested?
NIRS monitoring
How many people
40 participants
Where
1 siteFrance
Study dates
20 Jan 2020to 11 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 18 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children with craniosynostosis.

Who may be able to join

  • Boys and girls.
  • Aged 3 to 18 months old.
  • Subjects with a craniosynostosis diagnosis confirmed by imaging.
  • Craniosynostosis requiring a corrective surgery in ventral position.
  • Parents/ legal guardian must provide non opposition prior to participation in the study.

Who cannot join

  • Craniosynostosis planned to be corrected by an endoscopic craniectomy or in dorsal position.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospices Civils de Lyon service neurochirurgie pédiatrique

    Bron, 69500

Other trials in France

About this study

Official title: A Monocentric, Prospective Clinical Study to Evaluation of Cerebral Oxygen Saturation by Near InfraRed Spectroscopy (NIRS) in Children With Craniosynostosis

Craniosynostosis is a rare disorder characterized by a premature fusion of one or more sutures of the skull. Craniosynostosis is usually diagnosed in the first years of life. Several complications may be identified if untreated, notably, developmental delay, and vision problems.

In some patients with craniosynostosis a decrease in cerebral blood perfusion can be identified. It might be related to the constriction of the brain caused by premature sutural fusion or the localized constriction of venous sinuses.

Read more

In this study the investigator use the NIRS which is defined as a non-invasive technique to monitor hemodynamic parameters and hemoglobin oxygen saturation of the brain during the surgical correction of the craniosynostosis. By applying this method the investigator will be able to analyse the changes in cerebral hemoglobin oxygen saturation related to the modification of the skull.

Determining changes in brain oxygen saturation by using NIRS before, during and after surgery will help both to better understanding the impact of surgical decompression on improving cerebral oxygenation and to better adapt anaesthesia strategies during surgery.

Being tested
NIRS monitoring
Medical subject headings
Craniosynostoses

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NIRS monitoringOther

    Regional cerebral oxygen saturation (rScO₂) will be collected by NIRS monitoring before anesthesia induction, during surgery and after extubation, in children with craniosynostosis.

Study groups in NCT04086056
Study groupRoleWhat they receive
Children with craniosynostosisChildren with craniosynostosis who will be operated in prone position.
Receives: Other: NIRS monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Measured: Day 0 before anesthesia

  2. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Measured: Day 0 during surgery

  3. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Measured: Day 0 after extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start20 Jan 2020
  3. Primary completion11 Oct 2023
  4. Study completion11 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04086056
Sponsor's protocol ID
69HCL19_0568
Other IDs
2019-A02390-57
Acronym
CraNIRS
Status last verified
Feb 2024
First submitted
10 Sep 2019
Last updated
21 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Craniosynostoses, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Regional cerebral oxygen saturation measure (time frame: Day 0 before anesthesia). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in